Increased reporting of fatal pneumonitis associated with immune checkpoint inhibitors: a WHO pharmacovigilance database analysis
Year: 2020
Type: article
Study design: Observational Study
Abstract: There was an increased reporting of immune checkpoint inhibitor (ICI)-pneumonitis over the past few years with earlier time to onset of fatal ICI-pneumonitis, which was associated with more respiratory failure and tumour progressionhttp://bit.ly/32GW51a
Source: European Respiratory Journal
Institutions: Vidant Medical Center, East Carolina University, Inserm, Sorbonne Université, Assistance Publique – Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Groupe de REcherche en Cardio Oncologie, CIC Paris-est, Université Paris-Est Créteil, Hôpital Saint-Antoine, Epidemiology in dermatology and evaluation of therapeutics, Vanderbilt University Medical Center, Hôpital Tenon, THERANOSCAN : Biomarqueurs Théranostiques des Cancers Bronchiques Non à Petites Cellules
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W3007256753